Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
Critical Reviews in Oncology/Hematology|October 18, 2003
Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancerCharles L Bennett
Best Practice & Research. Clinical Haematology|March 29, 2005
The blue cross blue shield assessment technology review: summary of findingsCharles L Bennett
Science (New York, N.Y.)|February 12, 2005
Astrophysical observations: lensing and eclipsing Einstein's theoriesCharles L Bennett
Nature|April 28, 2006
Cosmology from start to finishCharles L Bennett
Science (New York, N.Y.)|September 12, 2009
Astronomy. Cosmology at a crossroadsCharles L Bennett
Cleveland Clinic Journal of Medicine|November 30, 2011
Pharmacovigilance and PML in the oncology settingCharles L Bennett
Archives of Internal Medicine|February 29, 2012
A 56-year-old physician who underwent a PSA testCharles L Bennett
The Lancet. Haematology|May 3, 2016
Thrombotic thrombocytopenic purpura: gaining knowledgeCharles L Bennett, Benjamin Djulbegovic
Blood|January 16, 2016
Big data, thromboembolism, and immunoglobulinCharles L Bennett, Terhi Hermanson
Archives of Internal Medicine|April 13, 2005
Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations?Anaadriana Zakarija, Charles L Bennett
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
Critical Reviews in Oncology/Hematology|October 18, 2003
Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancerCharles L Bennett
Best Practice & Research. Clinical Haematology|March 29, 2005
The blue cross blue shield assessment technology review: summary of findingsCharles L Bennett
Science (New York, N.Y.)|February 12, 2005
Astrophysical observations: lensing and eclipsing Einstein's theoriesCharles L Bennett
Nature|April 28, 2006
Cosmology from start to finishCharles L Bennett
Science (New York, N.Y.)|September 12, 2009
Astronomy. Cosmology at a crossroadsCharles L Bennett
Cleveland Clinic Journal of Medicine|November 30, 2011
Pharmacovigilance and PML in the oncology settingCharles L Bennett
Archives of Internal Medicine|February 29, 2012
A 56-year-old physician who underwent a PSA testCharles L Bennett
The Lancet. Haematology|May 3, 2016
Thrombotic thrombocytopenic purpura: gaining knowledgeCharles L Bennett, Benjamin Djulbegovic
Blood|January 16, 2016
Big data, thromboembolism, and immunoglobulinCharles L Bennett, Terhi Hermanson
Archives of Internal Medicine|April 13, 2005
Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations?Anaadriana Zakarija, Charles L Bennett
Pageof 34